当前位置: X-MOL 学术Cancer › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Strategies to improve diversity, equity, and inclusion in clinical trials
Cancer ( IF 6.2 ) Pub Date : 2021-09-08 , DOI: 10.1002/cncr.33905
Justine M Kahn 1 , Darrell M Gray 2 , Jill M Oliveri 3 , Chasity M Washington 4 , Cecilia R DeGraffinreid 3 , Electra D Paskett 3, 4, 5
Affiliation  

There is a growing need for diversity, equity, and inclusion (DEI) in cancer care, particularly with respect to equal access and accrual to clinical trials. This commentary describe steps taken to address disparities in the authors' own clinical practice and proposes actions at the patient, provider, community, and institution levels to improve DEI in clinical trials.

中文翻译:

提高临床试验多样性、公平性和包容性的策略

癌症护理中对多样性、公平性和包容性 (DEI) 的需求日益增长,特别是在临床试验的平等机会和应计权方面。本评论描述了为解决作者自身临床实践中的差异而采取的步骤,并提出了在患者、提供者、社区和机构层面改善临床试验中 DEI 的行动。
更新日期:2021-09-08
down
wechat
bug